Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest ...

Aurora Cannabis Inc. closed 37.64% short of its 52-week high of $7.20, which the company achieved on August 15th.

Aurora Cannabis Inc. closed 36.39% below its 52-week high of $7.20, which the company reached on August 15th.

Download the Complete Report Here By Rayk Riechmann Aurora Cannabis (Nasdaq: ACB) continued to fly high as it closed out fiscal 2025, with net revenue topping street estimates and prospects ...

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such ...

Canadian LPs offer better balance sheets and global potential vs. U.S. MSOs in cannabis investing. Find out why fundamentals favor names like VFF, OGI, and TLRY.

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are ...

Aurora Cannabis issued a press release on June 18, 2025, reporting its financial results for the Company's fiscal fourth quarter and full year.

Aurora Cannabis (NASDAQ:ACB) traded higher on Thursday after the company expanded the eligibility for its compassionate pricing program in Canada in a bid to widen access to its medical cannabis ...

Aurora Cannabis (NASDAQ:ACB) on Tuesday announced the launch of two new proprietary cultivars in Poland. Grown and manufactured in the company's Canadian GACP and EU-GMP facilities, the premium ...

Widely regarded as the largest cannabis operator by revenues, shares of Curaleaf Holdings CURLF have been declining persistently over the past few years due to regulatory hurdles and intensifying ...